Kumar Prabhash, Vanita Noronha, Akash Pawar, Ankush Shetake, Rajendra Badwe. "Reply to: Statistical and Methodological Considerations in the Evaluation of Ultra-Low-Dose Nivolumab." Journal of Clinical Oncology, 2026. doi:10.1200/jco-26-01376